Patient Guide: A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 75 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07037875
Status: NOT_YET_RECRUITING
Condition: GERD (Gastroesophageal Reflux Disease)
Phase: PHASE3

Where You Can Participate

This study is available at 75 locations across the country.

Top locations include:
  • • Sofia, Sofia City Province
  • • Sofia, Sofia City Province
  • • Sofia, Sofia City Province
  • • And 72 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD) - Join Clinical Trial NCTNCT07037875

How to Join This Clinical Trial - NCTNCT07037875

Learn how to participate in this PHASE3 trial studying an investigational therapy for GERD (Gastroesophageal Reflux Disease). Current status: NOT_YET_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with GERD (Gastroesophageal Reflux Disease). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
GERD (Gastroesophageal Reflux Disease)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
NOT_YET_RECRUITING
Study Identifier
NCTNCT07037875 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 75 locations. Find a study site near you:

Clinical Research Site

Sofia, Sofia City Province 1343 - Bulgaria

Status: Contact for availability

Clinical Research Site

Sofia, Sofia City Province 1407 - Bulgaria

Status: Contact for availability

Clinical Research Site

Sofia, Sofia City Province 1431 - Bulgaria

Status: Contact for availability

Clinical Research Site

Sofia, Sofia City Province 1463 - Bulgaria

Status: Contact for availability

Clinical Research Site

Sofia, Sofia City Province 1510 - Bulgaria

Status: Contact for availability

Clinical Research Site

Sofia, Sofia City Province 1527 - Bulgaria

Status: Contact for availability

Clinical Research Site

Sofia, Sofia City Province 1606 - Bulgaria

Status: Contact for availability

Clinical Research Site

Sofia, Sofia City Province 1618 - Bulgaria

Status: Contact for availability

Clinical Research Site

Dupnitsa, 2600 - Bulgaria

Status: Contact for availability

Clinical Research Site

Gorna Oryahovitsa, 5100 - Bulgaria

Status: Contact for availability

And 65 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for GERD (Gastroesophageal Reflux Disease):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships